Variant report

Variant	nsv533654
Chromosome Location	chr6:152664-184808
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:624)
CpG islands
(count:122)
Chromatin interactive
region (count:12)
LncRNA
region (count:17)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:624 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr6:157406-157408	K562	blood:	n/a	n/a
2	ARID3A	chr6:168940-169157	HepG2	liver:	n/a	n/a
3	ATF2	chr6:154306-155179	GM12878	blood:	n/a	n/a
4	ATF2	chr6:156670-157032	GM12878	blood:	n/a	n/a
5	ATF2	chr6:152980-153487	GM12878	blood:	n/a	n/a
6	ATF2	chr6:154275-155106	GM12878	blood:	n/a	n/a
7	ATF2	chr6:181000-181701	GM12878	blood:	n/a	n/a
8	ATF2	chr6:181047-181898	GM12878	blood:	n/a	n/a
9	BATF	chr6:154197-154629	GM12878	blood:	n/a	n/a
10	BATF	chr6:154252-155133	GM12878	blood:	n/a	n/a
11	BATF	chr6:156491-157009	GM12878	blood:	n/a	n/a
12	BATF	chr6:153034-153312	GM12878	blood:	n/a	n/a
13	BATF	chr6:181320-181669	GM12878	blood:	n/a	n/a
14	BATF	chr6:154691-155030	GM12878	blood:	n/a	n/a
15	BATF	chr6:183781-184092	GM12878	blood:	n/a	n/a
16	BATF	chr6:181382-181622	GM12878	blood:	n/a	n/a
17	BATF	chr6:152968-153416	GM12878	blood:	n/a	chr6:153318-153326
18	BATF	chr6:156683-156991	GM12878	blood:	n/a	n/a
19	BCL11A	chr6:181394-181586	GM12878	blood:	n/a	chr6:181481-181490
20	BCL11A	chr6:152949-153344	GM12878	blood:	n/a	n/a
21	BCL11A	chr6:156633-157058	GM12878	blood:	n/a	n/a
22	BCL11A	chr6:154309-155065	GM12878	blood:	n/a	n/a
23	BCL11A	chr6:153082-153258	GM12878	blood:	n/a	n/a
24	BCL11A	chr6:156702-156991	GM12878	blood:	n/a	n/a
25	BCL3	chr6:154627-155012	GM12878	blood:	n/a	n/a
26	BCL3	chr6:155810-156195	GM12878	blood:	n/a	n/a
27	BCL3	chr6:181242-181640	GM12878	blood:	n/a	chr6:181481-181490
28	BCL3	chr6:154271-155009	GM12878	blood:	n/a	n/a
29	BCLAF1	chr6:181165-181751	GM12878	blood:	n/a	chr6:181481-181490
30	BCLAF1	chr6:154574-155179	GM12878	blood:	n/a	n/a
31	BHLHE40	chr6:153089-153429	GM12878	blood:	n/a	n/a
32	BHLHE40	chr6:181240-181647	GM12878	blood:	n/a	n/a
33	BRCA1	chr6:181184-181190	GM12878	blood:	n/a	n/a
34	CEBPB	chr6:167215-167379	H1-hESC	embryonic stem cell:	n/a	chr6:167228-167239
35	CEBPB	chr6:168922-169138	A549	lung:	n/a	n/a
36	CEBPB	chr6:180266-180564	K562	blood:	n/a	n/a
37	CEBPB	chr6:168881-169187	K562	blood:	n/a	n/a
38	CEBPB	chr6:154313-155156	GM12878	blood:	n/a	n/a
39	CEBPB	chr6:175194-175390	Hela-S3	cervix:	n/a	n/a
40	CEBPB	chr6:152577-152790	IMR90	lung:	n/a	n/a
41	CEBPB	chr6:167122-167477	K562	blood:	n/a	chr6:167228-167239
42	CEBPB	chr6:174130-174338	HepG2	liver:	n/a	chr6:174244-174255
43	CEBPB	chr6:168835-169203	Hela-S3	cervix:	n/a	n/a
44	CEBPB	chr6:167170-167315	A549	lung:	n/a	chr6:167228-167239
45	CEBPB	chr6:167113-167409	Hela-S3	cervix:	n/a	chr6:167228-167239
46	CEBPB	chr6:167108-167420	HepG2	liver:	n/a	chr6:167228-167239
47	CEBPB	chr6:152500-152700	HepG2	liver:	n/a	n/a
48	CEBPB	chr6:168881-169126	HepG2	liver:	n/a	n/a
49	CEBPB	chr6:167167-167294	K562	blood:	n/a	chr6:167228-167239
50	CTCF	chr6:157260-157410	GM06990	blood:	n/a	chr6:157340-157353 chr6:157342-157350 chr6:157339-157360 chr6:157338-157354 chr6:157337-157355

(count:122 , 50 per page) page: 1 2 3

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr6:179456-179506	HCF	heart:	n/a
2	chr6:179456-179506	K562	blood:	n/a
3	chr6:179659-179709	AG10803	skin:	n/a
4	chr6:179659-179709	GM12878	blood:	n/a
5	chr6:179659-179709	HCM	heart:	n/a
6	chr6:179456-179506	Hela-S3	cervix:	n/a
7	chr6:179659-179709	Caco-2	colon:	n/a
8	chr6:179456-179506	HRE	kidney:	n/a
9	chr6:179456-179506	ECC-1	luminal epithelium:	n/a
10	chr6:179456-179506	U87	brain:	n/a
11	chr6:179659-179709	GM12891	blood:	n/a
12	chr6:179659-179709	A549	lung:	n/a
13	chr6:179456-179506	NHBE	bronchial:	n/a
14	chr6:179456-179506	LNCaP	prostate:	n/a
15	chr6:179659-179709	HAEpiC	amniotic membrane:	n/a
16	chr6:179659-179709	HIPEpiC	eye:	n/a
17	chr6:179456-179506	NT2-D1	testis:	n/a
18	chr6:179456-179506	SK-N-MC	brain:	n/a
19	chr6:179659-179709	K562	blood:	n/a
20	chr6:179456-179506	Hepatocyte	liver:	n/a
21	chr6:179659-179709	ovcar-3	ovarian:	n/a
22	chr6:179456-179506	IMR90	lung:	fetal
23	chr6:179659-179709	Hela-S3	cervix:	n/a
24	chr6:179659-179709	AG04449	skin:	fetal
25	chr6:179659-179709	NHDF-neo	bronchial:	n/a
26	chr6:179456-179506	BE2_C	brain:	n/a
27	chr6:179659-179709	T-47D	breast:	n/a
28	chr6:179456-179506	Jurkat	blood:	n/a
29	chr6:179659-179709	HEEpiC	esophagus:	n/a
30	chr6:179659-179709	RPTEC	kidney:	n/a
31	chr6:179659-179709	HPAEpiC	pulmonary alveolar:	n/a
32	chr6:179659-179709	AoSMC	blood vessel:	n/a
33	chr6:179456-179506	HUVEC	blood vessel:	n/a
34	chr6:179659-179709	HCT-116	colon:	n/a
35	chr6:179659-179709	HEK293	kidney:	embryo
36	chr6:179456-179506	AG09309	skin:	n/a
37	chr6:179659-179709	NHBE	bronchial:	n/a
38	chr6:179659-179709	AG09309	skin:	n/a
39	chr6:179456-179506	HEK293	kidney:	embryo
40	chr6:179659-179709	BE2_C	brain:	n/a
41	chr6:179456-179506	PrEC	prostate:	n/a
42	chr6:179456-179506	MCF10A-Er-Src	breast:	n/a
43	chr6:179659-179709	PrEC	prostate:	n/a
44	chr6:179659-179709	HRPEpiC	eye:	n/a
45	chr6:179456-179506	GM06990	blood:	n/a
46	chr6:179659-179709	NB4	blood:	n/a
47	chr6:179456-179506	Caco-2	colon:	n/a
48	chr6:179456-179506	AoSMC	blood vessel:	n/a
49	chr6:179659-179709	NT2-D1	testis:	n/a
50	chr6:179659-179709	MCF-7	breast:	n/a

(count:12 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr4:28899..29522-chr6:156896..157400,2	MCF-7	breast:
2	chr6:178419..181938-chr6:182767..184759,3	K562	blood:
3	chr6:178419..181938-chr6:182767..184759,3	K562	blood:
4	chr6:174671..177385-chr6:182024..184445,2	K562	blood:
5	chr6:181320..184707-chr6:184919..187235,3	K562	blood:
6	chr6:162155..164910-chr6:167837..169506,2	K562	blood:
7	chr6:182386..184733-chr6:187298..189526,2	K562	blood:
8	chr6:181397..184733-chr6:185247..188798,3	K562	blood:
9	chr4:29168..29759-chr6:156896..157405,3	MCF-7	breast:
10	chr6:174671..177385-chr6:182024..184445,2	K562	blood:
11	chr6:162155..164910-chr6:167837..169506,2	K562	blood:
12	chr6:181476..184276-chr6:186622..188907,2	MCF-7	breast:

(count:17 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-AL035696.1-2	chr6:183914-184371	XLOC_005117
2	lnc-AL035696.1-6	chr6:169950-170088	NONHSAT105973
3	lnc-EXOC2-20	chr6:171827-172220	NONHSAT105972
4	lnc-EXOC2-20	chr6:168171-170561	NONHSAT105972
5	lnc-AL035696.1-6	chr6:171079-171400	NONHSAT105973
6	lnc-AL035696.1-5	chr6:155135-155395	XLOC_005116
7	lnc-EXOC2-6	chr6:181466-181695	ENSG00000263667.1
8	lnc-EXOC2-20	chr6:169545-169753	NONHSAT105971
9	lnc-AL035696.1-2	chr6:184161-184371	NONHSAT105976
10	lnc-EXOC2-20	chr6:170352-170631	NONHSAT105971
11	lnc-EXOC2-20	chr6:167607-167826	NONHSAT105971
12	lnc-EXOC2-6	chr6:184593-184809	ENSG00000263667.1
13	lnc-AL035696.1-5	chr6:156119-156514	XLOC_005116
14	lnc-EXOC2-6	chr6:182366-182474	ENSG00000263667.1
15	lnc-AL035696.1-5	chr6:156546-156639	XLOC_005116
16	lnc-AL035696.1-2	chr6:184601-187741	XLOC_005117
17	lnc-AL035696.1-6	chr6:170686-171068	NONHSAT105973

No data

Variant related genes	Relation type
ENSG00000218577	TF binding region
ENSG00000218577	CpG island
TRRAP	miRNA target sites
TSC1	miRNA target sites

Extended variants
information (count: 415 )
Associated
traits (count: 60 )

Variant overlapped rSNPs/rCNVs (count:415 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs116166890	chr6:152749-152750	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs370021613	chr6:152779-152780	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs113265226	chr6:152998-152999	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
4	rs7746296	chr6:153012-153013	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
5	rs376490089	chr6:153226-153227	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
6	rs112590200	chr6:153295-153296	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
7	rs376351974	chr6:153304-153305	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
8	rs141664676	chr6:153432-153433	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs137867092	chr6:153439-153440	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs375770674	chr6:153449-153450	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs368928125	chr6:153504-153505	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs370888919	chr6:153523-153524	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs374220687	chr6:153581-153582	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs13436990	chr6:153714-153715	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs71548183	chr6:153727-153728	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs4120075	chr6:153735-153736	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs13437274	chr6:153778-153779	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs373160966	chr6:153927-153928	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs368276819	chr6:154024-154025	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs371025388	chr6:154125-154126	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs116545216	chr6:154203-154204	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs375387669	chr6:154264-154265	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs369977314	chr6:154286-154287	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs375950986	chr6:154337-154338	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs372985589	chr6:154493-154494	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs114520107	chr6:154536-154537	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs112464760	chr6:154567-154568	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs113038791	chr6:154579-154580	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs12524398	chr6:154694-154695	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs545744117	chr6:154738-154739	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs199991391	chr6:154749-154750	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs10484790	chr6:154750-154751	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs112970298	chr6:154788-154789	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs62388683	chr6:154801-154802	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs111545221	chr6:154846-154847	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs372936224	chr6:155212-155213	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
37	rs377224765	chr6:155432-155433	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs148337345	chr6:155577-155578	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs376960544	chr6:155578-155579	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs554239991	chr6:155601-155602	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs369981620	chr6:155685-155686	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs115670676	chr6:155815-155816	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs374495145	chr6:155941-155942	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs556551440	chr6:155975-155976	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs35385584	chr6:156003-156004	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
46	rs542002353	chr6:156025-156026	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
47	rs555580085	chr6:156034-156035	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
48	rs562550261	chr6:156062-156063	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
49	rs572310529	chr6:156096-156097	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
50	rs116072078	chr6:156100-156101	Weak transcription Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:60)

Disease	PMID	Source
Chronic lymphocytic leukemia	21546498	CNVD
Myelofibrosis	22110671	CNVD
Barrett''s adenocarcinoma	18663352	CNVD
Prader-willi syndrome	20588305	CNVD
Multiple myeloma	16616336	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Developmental delay	19490664	CNVD
Cancer	21183584	CNVD
Multiple Epiphyseal Dysplasia	20877625	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Glaucoma	18694899	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Prostate cancer	16573809	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Breast cancer	17603634	CNVD
Cancer	20164920	CNVD
Colorectal cancer	21297112	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Follicular lymphoma	20505157	CNVD
Glioblastoma multiforme	21080181	CNVD
Ewing''s sarcoma	21437220	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Leukemia	21518781	CNVD
Cancer	21637783	CNVD
Facial dysmorphism	22105932	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Endometrial cancer	22040021	CNVD
Acute myeloid leukemia	16864856	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Bladder cancer	19088036	CNVD
Wilms tumour	21544195	CNVD
Uveal melanoma	21693616	CNVD
Biliary cancer	19435499	CNVD
Malaria	21533027	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Autism	22495311	CNVD
small cell lung cancer	20016488	CNVD
Retinoblastoma	19183342	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Lung cancer	18438408	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Prostate cancer	18632612	CNVD

Chromatin state (count:118 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:149400-154200	Enhancers	GM12878-XiMat	blood
2	chr6:149800-153400	Weak transcription	Fetal Thymus	thymus
3	chr6:151800-155200	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
4	chr6:151800-155600	Enhancers	HMEC	breast
5	chr6:152000-153200	Weak transcription	Thymus	Thymus
6	chr6:152400-154000	Weak transcription	Placenta	Placenta
7	chr6:152800-153600	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
8	chr6:153000-153400	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
9	chr6:153000-155000	Enhancers	NHEK	skin
10	chr6:153200-153800	Enhancers	Thymus	Thymus
11	chr6:153400-154000	Enhancers	Fetal Thymus	thymus
12	chr6:153400-154800	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
13	chr6:153600-154600	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
14	chr6:153800-154200	Weak transcription	Thymus	Thymus
15	chr6:153800-154200	Enhancers	NHDF-Ad	bronchial
16	chr6:153800-157400	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
17	chr6:154000-155800	Weak transcription	Fetal Thymus	thymus
18	chr6:154000-157000	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
19	chr6:154200-154400	Enhancers	Placenta	Placenta
20	chr6:154200-154400	Enhancers	Thymus	Thymus
21	chr6:154200-154400	Flanking Active TSS	GM12878-XiMat	blood
22	chr6:154200-154600	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
23	chr6:154200-155000	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
24	chr6:154200-156200	Weak transcription	NHDF-Ad	bronchial
25	chr6:154400-154600	Enhancers	GM12878-XiMat	blood
26	chr6:154400-156200	Weak transcription	Thymus	Thymus
27	chr6:154600-155000	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
28	chr6:154600-155200	Flanking Active TSS	GM12878-XiMat	blood
29	chr6:154600-155200	Enhancers	Osteobl	bone
30	chr6:154600-156200	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
31	chr6:155000-155200	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
32	chr6:155000-155200	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
33	chr6:155000-155200	Enhancers	NHLF	lung
34	chr6:155200-156200	Weak transcription	NHLF	lung
35	chr6:155200-156400	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
36	chr6:155200-156600	Weak transcription	Osteobl	bone
37	chr6:155200-157000	Enhancers	GM12878-XiMat	blood
38	chr6:155600-156000	Weak transcription	HMEC	breast
39	chr6:155600-158000	Enhancers	Adipose Nuclei	Adipose
40	chr6:155800-158000	Enhancers	Fetal Thymus	thymus
41	chr6:156000-156200	Bivalent Enhancer	Fetal Muscle Trunk	muscle
42	chr6:156000-157600	Enhancers	HMEC	breast
43	chr6:156200-156400	Enhancers	Thymus	Thymus
44	chr6:156200-157000	Enhancers	NHLF	lung
45	chr6:156200-157200	Enhancers	NHDF-Ad	bronchial
46	chr6:156200-157400	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
47	chr6:156400-156800	Weak transcription	Thymus	Thymus
48	chr6:156400-157000	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
49	chr6:156800-157000	Enhancers	Osteobl	bone
50	chr6:156800-157600	Bivalent Enhancer	Primary T cells fromperipheralblood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links